Building evidence across borders

Bringing a healthcare innovation to market is one challenge, demonstrating its value across different healthcare systems is another. Clinical practice, reimbursement pathways, procurement processes, and stakeholder priorities vary from country to country, meaning that evidence generated in one market may not be sufficient to support adoption in another. For Dutch Life Sciences & Health organisations with international ambitions, building the right evidence strategy is often a critical step towards successful market access. 

This breakout discussion explores how organisations can generate the clinical, economic, and operational evidence needed to support international expansion. Drawing on practical experiences from industry, healthcare providers, and innovation ecosystems, speakers will discuss how to validate innovations across borders, adapt value propositions to local market needs, and build the confidence required for adoption by healthcare professionals and decision-makers.